These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8931926)

  • 21. "Dipeptoids": from the chemical structure of the endogenous peptide to the design of peptidomimetics.
    Martín-Martínez M; Patiño-Molina R; García-López MT; González-Muñiz R
    Mini Rev Med Chem; 2004 Aug; 4(6):669-80. PubMed ID: 15279601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of tachykinins in sephadex-induced airway hyperreactivity and inflammation in guinea pigs.
    Tramontana M; Santicioli P; Giuliani S; Catalioto RM; Lecci A; Carini F; Maggi CA
    Eur J Pharmacol; 2002 Mar; 439(1-3):149-58. PubMed ID: 11937105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tachykinin receptors in the modulation of colonic peristaltic activity in mice.
    Deiteren A; De Winter BY; Nullens S; Pelckmans PA; De Man JG
    Eur J Pharmacol; 2011 Sep; 667(1-3):339-47. PubMed ID: 21645508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor.
    Harikumar KG; Pinon DI; Wessels WS; Prendergast FG; Miller LJ
    J Biol Chem; 2002 May; 277(21):18552-60. PubMed ID: 11893747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A second generation of non-peptide cholecystokinin receptor antagonists and their possible therapeutic potential.
    Freedman SB; Patel S; Smith AJ; Chapman K; Fletcher A; Kemp JA; Marshall GR; Hargreaves RJ; Scholey K; Mellin EC
    Ann N Y Acad Sci; 1994 Mar; 713():312-8. PubMed ID: 8185173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS; Vigna SR
    Gen Comp Endocrinol; 1997 Jan; 105(1):91-101. PubMed ID: 9000471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally active nonpeptide CCK-A agonists.
    Sugg EE; Birkemo L; Gan LS; Tippin TK
    Pharm Biotechnol; 1998; 11():507-24. PubMed ID: 9760694
    [No Abstract]   [Full Text] [Related]  

  • 31. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
    Lemaire M; Böhme GA; Piot O; Roques BP; Blanchard JC
    Psychopharmacology (Berl); 1994 Aug; 115(4):435-40. PubMed ID: 7871086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
    Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tachykinins and tachykinin receptors: structure and activity relationships.
    Almeida TA; Rojo J; Nieto PM; Pinto FM; Hernandez M; Martín JD; Candenas ML
    Curr Med Chem; 2004 Aug; 11(15):2045-81. PubMed ID: 15279567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats.
    Polidori C; Ciccocioppo R; De Caro G; Massi M
    Peptides; 1998; 19(1):149-55. PubMed ID: 9437747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.
    Evans BE; Rittle KE; Bock MG; DiPardo RM; Freidinger RM; Whitter WL; Lundell GF; Veber DF; Anderson PS; Chang RS
    J Med Chem; 1988 Dec; 31(12):2235-46. PubMed ID: 2848124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular design of potent specific antagonists for the gastrin and cholecystokinin receptors.
    Evans BE
    Z Gastroenterol Verh; 1991 Mar; 26():269-71. PubMed ID: 1714170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tachykinins on identified dorsal vagal neurons: an electrophysiological study in vitro.
    Martini-Luccarini F; Reynaud JC; Puizillout JJ
    Neuroscience; 1996 Mar; 71(1):119-31. PubMed ID: 8834396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and potential utility of dual and triple NK receptor antagonists.
    Rizzo CA; Anthes JC; Corboz MR; Chapman RW; Shih NY; Reichard GA; Ng KJ; Hey JA
    Curr Top Med Chem; 2003; 3(12):1410-22. PubMed ID: 12871172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.